Tear Film-Based Diagnostics and Emerging Tissue Engineering Approaches in Personalized Dry Eye Disease Management

Current diagnostic kits have improved early detection and management of DED but are still limited by single parameter constraints, moderate reproducibility, and high costs. The combination of multiplex biomarker panels, biosensor technologies, and patient-specific organ-on-chip models is a promising deal toward precision diagnostics.